Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gail Boudreaux Insider Profile
4 Followers
Gail Boudreaux, Director at Novavax, holds 126.77K shares in Elevance Health (Ticker: ELV), holds 5.92K shares in Target (Ticker: TGT), holds 2.10K shares in Zimmer Biomet Holdings (Ticker: ZBH).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-10.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gail Boudreaux holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 06, 2019 - Feb 06, 2020
Return:+35.50%
The most profitable trade made by Gail Boudreaux
Gail Boudreaux's Trading History
Novavax
Sep 21, 2016
Director
Informative Buy
144.00K
$870.00K
Elevance Health
Jul 23, 2024
President & CEO, Director
Uninformative Sell
17.03M
$46.39M
Target
Mar 15, 2024
Director
Uninformative Buy
―
$778.10K
Xcel Energy
Feb 19, 2013
Director
Informative Buy
49.98K
$119.97K
Zimmer Biomet Holdings
Feb 06, 2019
Director
Informative Buy
249.98K
$224.42K
UnitedHealth
Sep 25, 2014
EVP & CEO, UnitedHealthcare
Uninformative Buy
―
$92.39M
List of latest transactions for each holding click on a transaction to see Gail Boudreaux's performance on stock
You May Also Like
Gail Boudreaux insider profile FAQ
What is the percentage of profitable transactions made by Gail Boudreaux?
The percentage of profitable transactions made by Gail Boudreaux is 50%.
What is the average return per transaction made by Gail Boudreaux?
The average return per transaction made by Gail Boudreaux is -10.00%.
What stocks does Gail Boudreaux hold?
Gail Boudreaux holds: NVAX, ELV, TGT, XEL, ZBH, UNH stocks.
What was Gail Boudreaux’s latest transaction?
Gail Boudreaux latest transaction was an Uninformative Sell of $17.03M.
What was Gail Boudreaux's most profitable transaction?
Gail Boudreaux’s most profitable transaction was an Informative Buy of ZBH stock on February 6, 2019. The return on the trade was 35.50%.
What is Gail Boudreaux's role in Novavax?
Gail Boudreaux's role in Novavax is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.